This question asks about the specific brand name or name under which the National AIDS Control Organisation (NACO) offers its Sexually Transmitted Infections (STI) and Reproductive Tract Infections (RTI) services across India.
The National AIDS Control Organisation (NACO) is a vital government body in India that works towards preventing and controlling HIV/AIDS. As part of its comprehensive approach to sexual health, NACO provides essential services for Sexually Transmitted Infections (STI) and Reproductive Tract Infections (RTI).
To ensure these services are easily identifiable and accessible to the public, NACO operates these specific clinics under a unified brand name. Based on the options provided, the correct brand name used by NACO for its STI/RTI services is:
These clinics are designed to offer confidential and quality diagnosis, treatment, and counselling for STIs and RTIs, contributing significantly to public sexual health and well-being.
STI/RTI services focus on the prevention, diagnosis, and management of infections that are transmitted through sexual contact, as well as other infections affecting the reproductive tract. These services are crucial for:
By branding these services as 'Suraksha Clinics', NACO aims to convey a message of safety, protection, and trust to the community seeking these important healthcare solutions.
A 42-year old man with history of alcohol dependency presents with progressive abdominal distension. Abdominal examination reveals a
shifting dullness. Which one of the following is the most appropriate drug to relieve this abdominal distension?
Which one of the following is the investigation of choice for diagnosing the presence of stones in the gall-bladder?
Which one of the following biologic agents used in the treatment of inflammatory Bowel Disease acts by inhibiting the enzyme 'Janus Kinase'?
Melanosis coli, which occurs due to long term consumption of stimulant laxatives, presents as brown dis-colouration of colonic mucosa due to
deposition of which one of the following pigments?
Consider the following with regard to Gilbert Syndrome:
I. Autosomal recessive trait of a mutation in gene for UDP- glucuronyl transferase enzyme
II. Elevation of unconjugated bilirubin
III. No stigmata of chronic liver disease other than jaundice
IV. Early Liver biopsy recommended in patients with possible Gilbert Syndrome
Which of the above are correct?